Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and 18F-FDG PET/CT

Abdominal Imaging

Volumn 40, Issue 4, 2014, Pages 843-851

  Ahn, Su Yeon ^a   Lee, Jeong Min ^a   Joo, Ijin ^a   Lee, Eun Sun ^b   Lee, Soo Jin ^a   Cheon, Gi Jeong ^a   Han, Joon Koo ^a   Choi, Byung Ihn ^a  

^a Seoul National University Hospital   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Microvascular invasion; MRI; PET CT

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE; GADOXETIC ACID; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; IMAGE ENHANCEMENT; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MICROVASCULATURE; MIDDLE AGED; MULTIMODAL IMAGING; NEOVASCULARIZATION (PATHOLOGY); NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PROCEDURES; RADIOGRAPHY; RETROSPECTIVE STUDY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TUMOR INVASION; VASCULARIZATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MICROVESSELS; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84939972981     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-014-0256-0     Document Type: Article

References (35)

1. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–2576
2. Kurtovic J, Riordan SM, Williams R (2005) Liver transplantation for hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 19:147–160
3. Zimmerman MA, Ghobrial RM, Tong MJ, et al. (2008) Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Arch Surg 143:182–188
4. Shetty K, Timmins K, Brensinger C, et al. (2004) Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl 10:911–918
5. Gouw AS, Balabaud C, Kusano H, et al. (2011) Markers for microvascular invasion in hepatocellular carcinoma: where do we stand? Liver Transpl 17:S72–S80
6. Kim KA, Kim MJ, Jeon HM, et al. (2012) Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images. J Magn Reson Imaging 35:629–634
7. Kim H, Park MS, Choi JY, et al. (2009) Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI? Eur Radiol 19:1744–1751
8. Chandarana H, Robinson E, Hajdu CH, et al. (2011) Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI? Am J Roentgenol 196:1083–1089
9. 18F-FDG-Uptake of hepatocellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients. Am J Transplant 9:592–600
10. Zech CJ, Vos B, Nordell A, et al. (2009) Vascular enhancement in early dynamic liver MR imaging in an animal model: comparison of two injection regimen and two different doses Gd-EOB-DTPA (gadoxetic acid) with standard Gd-DTPA. Invest Radiol 44:305–310
11. Lee MW, Lee JM, Lee JY, et al. (2006) Preoperative evaluation of the hepatic vascular anatomy in living liver donors: comparison of CT angiography and MR angiography. J Magn Reson Imaging 24:1081–1087
12. Nakashima Y, Nakashima O, Tanaka M, et al. (2003) Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol Res 26:142–147
13. Lee JW, Paeng JC, Kang KW, et al. (2009) Prediction of tumor recurrence by F-18-FDG PET in liver transplantation for hepatocellular carcinoma. J Nucl Med 50:682–687
14. Miyata R, Tanimoto A, Wakabayashi G, et al. (2006) Accuracy of preoperative prediction of microinvasion of portal vein in hepatocellular carcinoma using superparamagnetic iron oxide-enhanced magnetic resonance imaging and computed tomography during hepatic angiography. J Gastroenterol 41:987–995
15. Matsui O, Kobayashi S, Sanada J, et al. (2011) Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis. Abdom Imaging 36:264–272
16. Cheung TT, Chan SC, Ho CL, et al. (2011) Can positron emission tomography with the dual tracers [C-11] acetate and [F-18] fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma? Liver Transpl 17:1218–1225
17. 18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma. Cancer 117:4779–4787
18. Rodriguez-Peralvarez M, Luong TV, Andreana L, et al. (2013) A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol 20:325–339
19. Adam P, McMaster P, O’Grady JG, et al. (2003) Evolution of liver transplantation in Europe: Report of the European liver transplant registry. Liver Transplant 9:1231–1243
20. Broelsch CE, Malago M, Testa G, Gamazo CV (2000) Living donor liver transplantation in adults: outcome in Europe. Liver Transplant 6:S64–S65
21. Clavien PA, Lesurtel M, Bossuyt PMM, et al. (2012) Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol 13:E11–E22
22. Schroeder T, Malago M, Debatin JE, et al. (2005) “All-In-One” imaging protocols for the evaluation of potential living liver donors: comparison of magnetic resonance imaging and multidetector computed tomography. Liver Transpl 11:776–787
23. Hwang S, Lee SG, Belghiti J (2010) Liver transplantation for HCC: its role—Eastern and Western perspectives. J Hepatobiliary Pancreat Sci 17:443–448
24. Liang WH, Wu LW, Ling XT, et al. (2012) Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis. Liver Transpl 18:1226–1236
25. Mazzaferro V, Regalia E, Doci R, et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. New Engl J Med 334:693–699
26. Prasad KR, Young RS, Burra P, et al. (2011) Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement. Liver Transpl 17(Suppl 2):S81–S89
27. Mazzaferro V, Llovet JM, Miceli R, et al. (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35–43
28. Young AL, Lodge JP (2009) Needle-track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut 58(6):887–888
29. Sacks A, Peller PJ, Surasi DS, et al. (2011) Value of PET/CT in the management of primary hepatobiliary tumors, part 2. Am J Roentgenol 197:W260–W265
30. Khan MA, Combs CS, Brunt EM, et al. (2000) Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol 32:792–797
31. Park JW, Kim JH, Kim SK, et al. (2008) A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. J Nucl Med 49:1912–1921
32. Schwenzer NF, Schmidt H, Claussen CD (2012) Whole-body MR/PET: applications in abdominal imaging. Abdom Imaging 37:20–28
33. Pichler BJ, Kolb A, Nagele T, Schlemmer HP (2010) PET/MRI: paving the way for the next generation of clinical multimodality imaging applications. J Nucl Med 51:333–336
34. Choi JW, Lee JM, Kim SJ et al. (2013) Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR images and their value as an imaging biomarker. Radiology 267(3):776–786
35. Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. development, growth, and spread: key pathologic and imaging aspects. Radiology 272(3):635–654